Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit

Cardiovasc Res. 1998 Jan;37(1):239-46. doi: 10.1016/s0008-6363(97)00202-2.

Abstract

Objectives: Based on in vitro studies, oxidized low-density lipoprotein (oxLDL) has been implicated in atherogenesis and the associated deficiency in endothelium-dependent relaxation. The aim of this study was to investigate the effects of in vivo exposure to oxLDL on intimal thickening and relaxing behaviour.

Methods: Intimal thickening was evoked by the placement of silicone collars around the carotid arteries of the rabbit for 3 or 14 days. OxLDL (Cu(2+)-oxidized, 7 micron/h) or the vehicle phosphate-buffered saline (PBS) was infused in the collars via subdermally implanted osmotic minipumps.

Results: The collared vessels receiving PBS developed discrete intimal thickening after 14 days (intima/media (I/M) ratio 11 +/- 2%). OxLDL infusion resulted in intimal thickening after 3 days and significantly enhanced the intimal thickness by 14 days (I/M ratio 98 +/- 16%). Collaring alone for 3 or 14 days and 3 days exposure to oxLDL did not impair the endothelium-dependent relaxations to acetylcholine or calcium ionophore, nor to the NO donors glyceryl trinitrate (GTN) and S-nitroso-N-acetylpenicillamine (SNAP). However, the sensitivity to acetylcholine was decreased after exposure to oxLDL for 14 days (-logEC50 oxLDL 6.95 +/- 0.11 vs. 7.52 +/- 0.11 collar alone) and the maximal relaxation to the endothelium-dependent agonist was reduced by 50%, this in the presence of a virtually intact endothelium. Complete relaxation was still obtained with the nitric oxide donors.

Conclusion: Our results show for the first time that local vascular exposure to oxLDL in vivo promotes intimal thickening and inhibits endothelium-dependent dilation, thereby supporting an active role for oxLDL in the morphological and functional changes observed in atherosclerotic blood vessels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Calcimycin / pharmacology
  • Copper / pharmacology
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects*
  • Ionophores / pharmacology
  • Lipid Peroxidation
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, LDL / pharmacology*
  • Male
  • Nitroglycerin / pharmacology
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Phenylephrine / pharmacology
  • Rabbits
  • S-Nitroso-N-Acetylpenicillamine
  • Tunica Intima / drug effects*
  • Tunica Intima / pathology
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology

Substances

  • Ionophores
  • Lipoproteins, LDL
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Phenylephrine
  • Calcimycin
  • Copper
  • S-Nitroso-N-Acetylpenicillamine
  • cuprous chloride
  • Nitroglycerin
  • Penicillamine
  • Acetylcholine